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The caseous lymphadenitis (CLA) is a common disease
that affects ruminants around the world. The CLA is
caused by gram-positive bacteria known as Corynebac-
terium pseudotuberculosis, which is an intracellular
facultative pathogen. In Brazil, the high prevalence
occurs principally in northeast and southwest, where
has the major herd of sheep and goat causing important
economic losses. The actual commercial vaccine confers
some level of protection and as based in attenuated or
inactive bacteria. The third generation of vaccine
includes the DNA vaccine, which can give some advan-
tages as does not cause infection and the stability [1-3].
Thus the aim of this study was develop and evaluate
DNA vaccines based on genes that encode for secreted
proteins of C. pseudotuberculosis. For this, we cloned on
eukaryotic expression pTARGET vector, gene fragments
of C. pseudotuberculosis namely Cp1002_1957 and
Cp1002_1802, which encoded for the LipY protein and
transferase B protein, respectively. After PCR using spe-
cific primers to each gene, the encode sequence were
ligated on pTARGET vector (Promega) and the ligation
reaction was used to transform Escherichia coli Top10
by eletroporation. The transformation was plated in LB
with ampicilin and X-gal substrate. After incubation, the
white colonies were select for a screening by digestion
with the enzyme EcoRI to confirm gene insertion on
vector. Five clones of each gene are selected to transfec-
tion of the CHO cells in order to confirm the expression
level of proteins by indirect immunofluorescence using
sera of mice immunized with the recombinant proteins
(rCP1957 and rCP1802). The immunofluorescence ana-
lysis show high levels of protein expression (CP1957 and
Cp1802) in CHO cells in all clones tested. Both DNA
vaccines (pTARGET/1802 and pTARGET/1957) are able
to express the proteins in CHO cells in vitro. On the
next step, we will perform the animal immunization to
confirm the protection level (challenge test) and the
immunomodulatory response.
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